The FDA's authorization of Aletta marks a significant milestone in the development of medical robotics. Aletta uses near-infrared light and Doppler ultrasound to locate a suitable vein and can perform all steps of the blood draw with the oversight of a trained phlebotomist.
Key Insights
Aletta is the first standalone robotic device authorized by the FDA to draw blood, and it can autonomously handle all steps of the blood draw, including locating a vein and inserting a needle. One phlebotomist can oversee up to three Aletta devices simultaneously, with the device achieving successful blood-draw rates comparable to or better than those of trained human phlebotomists.
